Cardiovascular and Renal Effects of the β-Blocker SE2395 in Conscious Normotensive Dogs
- 1 November 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 7 (6) , 1193-1197
- https://doi.org/10.1097/00005344-198511000-00029
Abstract
Summary: The cardiac and renal hemodynamic effects of SE2395, a β-blocking agent, were examined after intravenous administration (50 μg/kg) in normotensive conscious dogs. β-blocking action of SE2395 was evidenced by a reduction in heart rate and cardiac output without change in the mean arterial pressure. An increase in glomerular filtration rate (inulin clearance) and a slight enhancement in effective renal plasma flow (para-aminohippurate clearance) were observed without attendant decreases in plasma renin activity. An increase in urinary sodium excretion was also observed; urinary prostaglandin E2 excretion was, however, unchanged. We conclude that at effective β-blocking dosage SE2395 does not induce any detrimental effect on renal function in conscious dogs.Keywords
This publication has 7 references indexed in Scilit:
- Renal function in conscious rats after indomethacin. Evidence for a tubular action of endogenous prostaglandins.The Journal of Physiology, 1980
- Effect of Nadolol in Treatment of HypertensionThe Journal of Clinical Pharmacology, 1979
- Mechanism of Effect of Hypoxia on Renal Water ExcretionJournal of Clinical Investigation, 1978
- Contribution of prostaglandins to the renal circulation in conscious, anesthetized, and laparotomized dogs.Circulation Research, 1977
- Inhibition of sodium transport by prostaglandin E2 across the isolated, perfused rabbit collecting tubule.Journal of Clinical Investigation, 1977
- EFFECT OF SOME BETA-ADRENERGIC BLOCKING-DRUGS ON RENAL BLOOD-FLOW IN DOGS1977
- beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction.Circulation Research, 1976